U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904845) titled 'A Study of BON-C1393 in Adults With Advanced Solid Tumors' on Oct. 23.
Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of BON-C1393 monotherapy or in combination with other anticancer regimens in adults with selected advanced solid tumors. The study will consist of Phase 1a (Dose Escalation and Dose Exploration) and Phase 1b (Dose Expansion).
Study Start Date: Nov. 23
Study Type: INTERVENTIONAL
Condition:
Solid Tumors
Advanced Solid Tumors
Intervention:
DRUG: BON-C1393
Administered intravenously
DRUG: Bevacizumab
Administered intrave...